Biotech Amgen acquires UK-based Dark Blue Therapeutics in $840m deal

The acquisition will enable Amgen to further its research and improve the development of cancer-targeting treatments.

Read more: Biotech Amgen acquires UK-based Dark Blue Therapeutics in $840m deal